Suppr超能文献

冷冻辅助向多药耐药癌细胞进行细胞内药物递送

Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells.

作者信息

Teo Ka Yaw, Han Bumsoo

机构信息

Department of Mechanical and Aerospace Engineering, University of Texas at Arlington, Arlington, TX 76019, USA.

出版信息

J Biomech Eng. 2009 Jul;131(7):074513. doi: 10.1115/1.3153325.

Abstract

The efficacy of chemotherapy is significantly impaired by the multidrug resistance (MDR) of cancer cells. The mechanism of MDR is associated with the overexpression of certain adenosine triphosphate-binding cassette protein transporters in plasma membranes, which actively pump out cytotoxic drugs from the intracellular space. In this study, we tested a hypothesis that freezing and thawing (F/T) may enhance intracellular drug delivery to MDR cancer cells via F/T-induced denaturation of MDR-associated proteins and/or membrane permeabilization. After a human MDR cancer cell line (NCI/ADR-RES) was exposed to several F/T conditions, its cellular drug uptake was quantified by a fluorescent calcein assay using calcein as a model drug. After F/T to -20 degrees C, the intracellular uptake of calcein increased by 70.1% (n=5, P=0.0004). It further increased to 118% as NCI/ADR-RES cells were frozen/thawed to -40 degrees C (n=3, P=0.009). These results support the hypothesis, and possible mechanisms of F/T-enhanced intracellular drug delivery were proposed and discussed.

摘要

癌细胞的多药耐药性(MDR)显著削弱了化疗的疗效。MDR的机制与质膜中某些三磷酸腺苷结合盒蛋白转运体的过表达有关,这些转运体可将细胞毒性药物从细胞内空间主动泵出。在本研究中,我们测试了一个假设,即冻融(F/T)可能通过F/T诱导的MDR相关蛋白变性和/或膜通透性增加,增强细胞内药物向MDR癌细胞的递送。将人MDR癌细胞系(NCI/ADR-RES)暴露于几种F/T条件后,以荧光素为模型药物,通过荧光素酶检测法定量其细胞药物摄取。在冻融至-20℃后,荧光素的细胞内摄取增加了70.1%(n=5,P=0.0004)。当NCI/ADR-RES细胞冻融至-40℃时,其摄取进一步增加至118%(n=3,P=0.009)。这些结果支持了该假设,并提出并讨论了F/T增强细胞内药物递送的可能机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验